Xylazine and the Controlled Substances Act: Legal Considerations for Congress
Full report
What this is
The Congressional Research Service is a nonpartisan policy and legal analysis arm of the Library of Congress. CRS reports are written for members of Congress and their staff, not the public — but they’re made available openly through Congress.gov.
- HR 1734118th Congress
TRANQ Research Act of 2023
Dec 19, 2023 · Became Public Law No: 118-23.
- HR 1839118th Congress
Combating Illicit Xylazine Act
Apr 7, 2023 · Referred to the Subcommittee on Health.
- HR 4106118th Congress
Test Strip Access Act of 2023
Jun 16, 2023 · Referred to the Subcommittee on Health.
- HR 4531118th Congress
Support for Patients and Communities Reauthorization Act
Dec 13, 2023 · Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- HR 5801118th Congress
Preventing Overdoses with Test Strips Act
Sep 29, 2023 · Referred to the Subcommittee on Health.
- HR 7226118th Congress
ALERT Communities Act
Feb 9, 2024 · Referred to the Subcommittee on Health.
- S 2484118th Congress
Expanding Nationwide Access to Test Strips Act
Jul 25, 2023 · Read twice and referred to the Committee on the Judiciary.
- S 2569118th Congress
Fentanyl Safe Testing and Overdose Prevention Act
Jul 27, 2023 · Read twice and referred to the Committee on the Judiciary.
- S 2919118th Congress
ALERT Communities Act
Sep 26, 2023 · Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- S 4025118th Congress
STOP TRANQ Act
Mar 21, 2024 · Read twice and referred to the Committee on Foreign Relations.
- S 993118th Congress
Combating Illicit Xylazine Act
Jan 11, 2024 · Committee on Banking, Housing, and Urban Affairs. Hearings held.